CA-CEPTON-TECHNOLOGIES
18.10.2019 00:02:05 CEST | Business Wire | Press release
A new technology partnership is set to transform road tolling for both providers and motorists alike by utilizing the latest advances in lidar technology and data analytics.
Cepton Technologies, Inc. has collaborated with industrial perception and machine learning experts, MechaSpin, to develop a lidar-based solution that produces detailed 3D classification of vehicles in real time for automated tolling applications. This next-generation solution combines Cepton’s Sora-P60 with MechaSpin’s MSx software to enable immediate profiling and classification of vehicles at highway speeds in a wide range of weather and lighting conditions.
Traditional tolling systems often depend on physical infrastructure to reduce vehicle speed, or tollbooths to allow for manual processing, which can cause congestion and frustration amongst motorists. Advanced systems that allow for faster tolling, however, are often subject to abuses such as leakage, while road-based sensors often fail due to wear and tear.
Cepton and MechaSpin’s solution addresses such challenges by eliminating the need for physical infrastructure while providing accurate data, such as vehicle velocity, size and axle count, in a format that can be integrated with other sensor, data capture and billing systems. At the same time, the hardware is designed for aerial installation and contains minimal moving parts, reducing the likelihood of failure.
Neil Huntingdon, Cepton’s VP of Business Development, said: “Our partnership with MechaSpin is founded on both businesses’ deep understanding of the unique and powerful capabilities of lidar, especially when it is teamed with problem solving software solutions.
“We believe that this partnership will bring major innovations to the tolling industry. Our Sora-P60 lidar delivers an unrivalled scan speed at 380Hz, making it possible to profile vehicles as they pass at highway speeds. Our partnership with MechaSpin will allow for faster, more accurate and lower cost management of our transport infrastructure as the number of vehicles continues to grow globally.”
Danny Kent, PhD, MechaSpin’s President, added: “The tolling industry lacks an integrated end-to-end solution for deploying 3D lidar for vehicle classification and tracking. MechaSpin and Cepton have partnered to deliver a solution for this need. Cepton's lidar technology coupled with MechaSpin's MSx Processing Engine offers a robust solution for tolling, intermodal and other transportation industry applications.”
Cepton will be showcasing its state-of-the-art lidar solutions at the 26th ITS World Congress in Singapore from October 21 to October 25, 2019. Please visit Cepton’s booth (B04) for more information or to arrange a live demo.
Founded in 2016 by Dr. Jun Pei and Dr. Mark McCord, Cepton is the only company in the industry to ship high-performance and low-cost lidar sensors directly to customers.
Lidar technology is not new, however its usage across industries is growing thanks to its power efficient, environmentally agnostic qualities. Like bats, which use sound waves during echolocation to measure distances and determine the location of an object, lidar utilises light waves from a laser to send a pulse of light and measure the amount of time it takes to reflect back from objects, making it possible to measure the distance between them. Since the speed of light is constant, distance can be easily calculated by measuring the time it takes for the beam to return.
Lidar systems use these pulses to create three-dimensional point clouds of their surrounding area, providing cars and other smart machines with highly accurate perception data to autonomously navigate.
Cepton's Micro Motion Technology (MMT™) is unique to the industry. Unlike traditional beam-steering technologies, such as spinning lidar and micro-electronical mechanical systems (MEMS), Cepton’s MMT architecture enables a mirrorless, frictionless and rotation-free system to increase the durability, reliability and manufacturability of the product, while delivering industry-leading range and resolution for highly accurate 3D sensing.
For more information about Cepton Technologies Inc., visit www.cepton.com
For more information about MechaSpin visit www.mechaspin.com
About Cepton Technologies, Inc.
Cepton Technologies, Inc. is a 3D sensing solutions provider shipping state-of-the-art lidar products for the automotive, security, transport infrastructure, industrial, IoT and mapping markets.
Founded in 2016 and led by industry veterans with deep experience in lidar and advanced imaging, Cepton is focused on the mass market commercialization of high performance, high quality lidar solutions for the automotive industry and beyond.
Cepton’s patented lidar technology delivers outstanding detection range and resolution, reliability and affordability, to enable perception for the fast-growing market for autonomous and smart machines.
For more information, visit: http://www.cepton.com/ .
Cepton is headquartered in San Jose, California, USA.
It also has offices in Germany, Canada and UK.
About MechaSpin
MechaSpin is an experienced Systems Integrator and Solution Provider dedicated to using lidar technology to make the world safer, more efficient and more productive. MechaSpin’s MSx Processing Engine provides advanced signal processing and machine learning algorithms for 3D lidar data.
Founded in 2010, MechaSpin is led by engineers that started their careers as participants in the DARPA Grand Challenges, fielding lidar technology for autonomous robotic vehicles. MechaSpin’s team is focused on bringing sensors, algorithms and technologies from the self-driving car industry into industrial markets such as material handling, tolling, port and terminal, intermodal, and more.
For more information, visit: http://www.mechaspin.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20191017005006/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom